Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 1 1

Status

Completed 3

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Prostatic Neoplasms 3Herpes Zoster 3Breast Neoplasms 3Uterine Cervical Neoplasms 2Uterine Cervical Dysplasia 2Papillomavirus Infections 2Neoplasms 2Melanoma 2Lung Neoplasms 2Influenza, Human 2Glioblastoma 2Whooping Cough 1Waldenstrom Macroglobulinemia 1Tetanus 1Spondylitis, Ankylosing 1Psoriasis 1Pancreatic Neoplasms 1Neuroectodermal Tumors, Primitive 1Neoplasms, Glandular and Epithelial 1Multiple Myeloma 1Meningitis 1Medulloblastoma 1Hematologic Neoplasms 1Glioma 1Diphtheria 1Diabetes Mellitus, Insulin-Dependent, 12 1Crohn Disease 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms, Male 1

Interventions

Vaccines 3Herpes Zoster Vaccine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Has results × Herpes Zoster × Vaccines × Clear all
NCT01798056 2021-05-13

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ/su) Vaccine in Adults With Solid Tumours Receiving Chemotherapy

GlaxoSmithKline

Phase 3 Completed
237 enrolled 20 charts

Herpes Zoster

NCT01254630 2019-09-30

V212-011

Merck Sharp & Dohme LLC

Phase 3 Completed
5,305 enrolled 20 charts
Other hematologic neoplasm

Herpes Zoster, Hematologic Neoplasms

NCT01460719 2019-03-11

V212-013

Merck Sharp & Dohme LLC

Phase 1 Completed
80 enrolled 13 charts

Herpes Zoster

Data powered by HemOnc (CC BY 4.0) Colophon âš¡